For example, SLC2A3 was hypermethylated in BLCA, BRCA, head and neck squamous cell carcinoma (HNSC), kidney renal papillary cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD), and UCEC but hypomethylated in COAD and kidney renal clear cell carcinoma (KIRC). This evidence concerns the gene SLC2A3 and prostate adenocarcinoma.